BR112022021691A2 - Moduladores de receptor de glicocorticoide (gr) para tratar um vírus sars-cov-2 - Google Patents
Moduladores de receptor de glicocorticoide (gr) para tratar um vírus sars-cov-2Info
- Publication number
- BR112022021691A2 BR112022021691A2 BR112022021691A BR112022021691A BR112022021691A2 BR 112022021691 A2 BR112022021691 A2 BR 112022021691A2 BR 112022021691 A BR112022021691 A BR 112022021691A BR 112022021691 A BR112022021691 A BR 112022021691A BR 112022021691 A2 BR112022021691 A2 BR 112022021691A2
- Authority
- BR
- Brazil
- Prior art keywords
- cov
- sars
- modulators
- virus
- treat
- Prior art date
Links
- 102000003676 Glucocorticoid Receptors Human genes 0.000 title abstract 4
- 108090000079 Glucocorticoid Receptors Proteins 0.000 title abstract 4
- 241000700605 Viruses Species 0.000 title abstract 2
- 102000016289 Cell Adhesion Molecules Human genes 0.000 abstract 2
- 108010067225 Cell Adhesion Molecules Proteins 0.000 abstract 2
- 239000003862 glucocorticoid Substances 0.000 abstract 1
- 230000007246 mechanism Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229940037128 systemic glucocorticoids Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063017199P | 2020-04-29 | 2020-04-29 | |
| PCT/US2021/029608 WO2021222385A1 (en) | 2020-04-29 | 2021-04-28 | Glucocorticoid receptor (gr) modulators for treating a sars-cov-2 virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022021691A2 true BR112022021691A2 (pt) | 2022-12-20 |
Family
ID=76270026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022021691A BR112022021691A2 (pt) | 2020-04-29 | 2021-04-28 | Moduladores de receptor de glicocorticoide (gr) para tratar um vírus sars-cov-2 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230172950A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4142736A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023524434A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230015927A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115666583A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022021691A2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021222385A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021247000A1 (en) | 2020-06-01 | 2021-12-09 | Avm Biotechnology, Llc | Methods of treatment using icam-modulating agents |
| EP4426317A1 (en) * | 2021-11-05 | 2024-09-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of low molecular weight hyaluronic acid for the treatment of lung mucosal inflammation |
| CN114028571B (zh) * | 2021-11-18 | 2023-04-28 | 中国医学科学院基础医学研究所 | 含氮双膦酸盐联合糖皮质激素在预防或治疗病毒性肺炎中的应用 |
| CN114099481B (zh) * | 2022-01-28 | 2022-05-24 | 深圳湾实验室 | 雾化吸入型糖皮质激素纳米药物及其制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110475571B (zh) | 2017-04-01 | 2023-04-04 | Avm生物技术有限责任公司 | 细胞免疫疗法前细胞毒性预调理的替代 |
| EP3488851A1 (en) * | 2018-10-03 | 2019-05-29 | AVM Biotechnology, LLC | Immunoablative therapies |
| KR20220148859A (ko) * | 2020-02-28 | 2022-11-07 | 에이브이엠 바이오테크놀로지, 엘엘씨 | 림프구 집단 및 이를 생산하는 방법 |
-
2021
- 2021-04-28 US US17/921,128 patent/US20230172950A1/en active Pending
- 2021-04-28 CN CN202180031406.4A patent/CN115666583A/zh active Pending
- 2021-04-28 WO PCT/US2021/029608 patent/WO2021222385A1/en not_active Ceased
- 2021-04-28 JP JP2022565781A patent/JP2023524434A/ja active Pending
- 2021-04-28 EP EP21729980.9A patent/EP4142736A1/en active Pending
- 2021-04-28 BR BR112022021691A patent/BR112022021691A2/pt unknown
- 2021-04-28 KR KR1020227041735A patent/KR20230015927A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230015927A (ko) | 2023-01-31 |
| JP2023524434A (ja) | 2023-06-12 |
| WO2021222385A1 (en) | 2021-11-04 |
| EP4142736A1 (en) | 2023-03-08 |
| US20230172950A1 (en) | 2023-06-08 |
| CN115666583A (zh) | 2023-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2020106642A8 (en) | 2-formyl-3-hydroxyphenyloxymethyl compounds capable of modulating hemoglobin | |
| EP4559517A3 (en) | Microcurrent stimulation therapy apparatus and method | |
| BR112021021703A2 (pt) | Cicloalquilas substituídas como moduladores da via de estresse integrada | |
| EP4491234A3 (en) | Multi-specific binding proteins for activation of natural killer cells and therapeutic uses thereof to treat cancer | |
| AR118859A1 (es) | Composiciones y métodos de fabricación de células t | |
| AU2018281308A1 (en) | Methods and apparatuses for the thermal treatment of neurologic and psychiatric disorders | |
| MX2022003193A (es) | Tratamiento de encefalopatia asociada al gen syngap1. | |
| BR112023005160A2 (pt) | Terapia de combinação para o tratamento de câncer | |
| BR112015030595A2 (pt) | moduladores de receptor de estrogênio de azetidina e usos dos mesmos | |
| BR112022026236A2 (pt) | Terapia de combinação de imuno-oncologia com conjugados de il-2 e anticorpos anti-egfr | |
| EP4035664A3 (en) | Treating cancer using selective estrogen receptor modulators | |
| BR112012007239A2 (pt) | moléculas de ligação biespecíficas para terapia antiangiogênese | |
| UA107812C2 (xx) | ДВОЗАМІЩЕНІ ОКТАГІДРОПІРОЛО$3,4-с]ПІРОЛИ ЯК МОДУЛЯТОРИ ОРЕКСИНОВИХ РЕЦЕПТОРІВ | |
| BR112018073518A2 (pt) | métodos para sensibilização de células de câncer a um tratamento anticâncer, para potencialização do efeito terapêutico de um tratamento anticâncer e para tratamento de câncer, composição, modulador de canais de ânion regulados por volume, kit de peças, e, uso de um modulador de canais de ânion regulados por volume | |
| MY178120A (en) | Anti sez6 antibodies and methods of use | |
| NO20091966L (no) | Sammensetninger og fremgangsmater for a redusere proliferasjon av endometrie | |
| SG10201806867VA (en) | Dll3 modulators and methods of use | |
| WO2010111400A3 (en) | Method and kits for treating appetite suppressing disorders and disorders with an increased metabolic rate | |
| UA111476C2 (uk) | Оксазольні та ізоксазольні похідні як модулятори crac | |
| BR112022004497A2 (pt) | Administração intranasal de escetamina | |
| BR112018002524A2 (pt) | modificação em catalisadores para controlar a arquitetura polimérica | |
| WO2016061320A3 (en) | Timber therapy for post-traumatic stress disorder | |
| BR112022021732A2 (pt) | Tratamentos de câncer de próstata com combinações de acetato de abiraterona e niraparibe | |
| BR112022010934A2 (pt) | Métodos para tratar copd administrando um antagonista de il-33 | |
| BR112022025128A2 (pt) | Composições e métodos para tratar doenças e distúrbios usando vesículas extracelulares microbianas de oscillospiraceae |